Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,075 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience.
Sakamoto H, Itonaga H, Sawayama Y, Furumoto T, Fujioka M, Chiwata M, Toriyama E, Kasai S, Nakashima J, Horai M, Kato T, Sato S, Ando K, Taguchi J, Imaizumi Y, Yoshida S, Hata T, Moriuchi Y, Miyazaki Y. Sakamoto H, et al. Hematol Oncol. 2020 Apr;38(2):162-170. doi: 10.1002/hon.2712. Epub 2020 Jan 26. Hematol Oncol. 2020. PMID: 31922287
[Ectopic pulmonary calcification after parathyroidectomy in multiple myeloma].
Ando K, Imaizumi Y, Yamamoto K, Tanaka M, Zaizen Y, Taguchi M, Sakaki C, Ichinose M, Furumoto T, Hashimoto M, Fujioka M, Sakamoto H, Hourai M, Itonaga H, Sato S, Sawayama Y, Hata T, Mukae H, Fukuoka J, Inoue D, Miyazaki Y. Ando K, et al. Among authors: sakamoto h. Rinsho Ketsueki. 2019;60(7):785-790. doi: 10.11406/rinketsu.60.785. Rinsho Ketsueki. 2019. PMID: 31391367 Japanese.
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group.
Chiwata M, Itonaga H, Sato S, Hashimoto M, Fujioka M, Kasai S, Sakamoto H, Toriyama E, Nakashima J, Kamijo R, Kitanosono H, Kobayashi Y, Horai M, Taguchi M, Matsuo M, Makiyama J, Takasaki Y, Matsuo E, Horio K, Ando K, Sawayama Y, Taguchi J, Kawaguchi Y, Tsushima H, Imanishi D, Imaizumi Y, Yoshida S, Jo T, Nonaka H, Moriuchi Y, Nagai K, Yokota KI, Hata T, Miyazaki Y. Chiwata M, et al. Among authors: sakamoto h. Intern Med. 2021 Jul 15;60(14):2207-2216. doi: 10.2169/internalmedicine.6620-20. Epub 2021 Feb 22. Intern Med. 2021. PMID: 33612681 Free PMC article.
The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group Experience.
Fujioka M, Itonaga H, Furumoto T, Kasai S, Sakamoto H, Kitanosono H, Kato T, Horai M, Sato S, Sawayama Y, Taguchi J, Imaizumi Y, Hata T, Yoshida S, Moriuchi Y, Miyazaki Y. Fujioka M, et al. Among authors: sakamoto h. Transpl Immunol. 2021 Aug;67:101417. doi: 10.1016/j.trim.2021.101417. Epub 2021 May 28. Transpl Immunol. 2021. PMID: 34058354
Clinical features of non-infectious pulmonary complications after donor lymphocyte infusion in post-transplant patients: The Nagasaki Transplant Group Experience.
Fujioka M, Itonaga H, Furumoto T, Sakaki C, Sakamoto H, Kato T, Horai M, Taguchi M, Sawayama Y, Taguchi J, Imaizumi Y, Yoshida S, Moriuchi Y, Miyazaki Y. Fujioka M, et al. Among authors: sakamoto h. Transpl Immunol. 2022 Dec;75:101707. doi: 10.1016/j.trim.2022.101707. Epub 2022 Sep 8. Transpl Immunol. 2022. PMID: 36087807
3,075 results